PS Plus Premium Offers 7 Free Game Trials in October 2026: A Closer Look

PS Plus Premium Offers 7 Free Game Trials in October 2026: A Closer Look

  • Tags
  • Gaming News
  • PS5
  • PlayStation Plus
  • Game Trials
  • A Plague Tale

As October 2026 unfolds, Sony continues to bolster its PlayStation Plus subscription service by introducing an exciting new selection of game trials for Premium members. In addition to the monthly catalogue updates, subscribers can now experience seven major titles released in 2026 at no extra cost for a limited time.

Accessing Exclusive Trials

PlayStation Plus Premium provides a unique "Game Trials" feature that allows users to download and play full versions of selected games before committing to a purchase. This trial period is an excellent way for players to test the mechanics and atmosphere of recent releases without financial risk.

Featured Titles in the October Selection

The current lineup features a mix of anticipated sequels and engaging indie experiences. The following games are now available for limited-time trials:

  • Resonance: A Plague Tale Legacy: 2 hours of free gameplay.
  • Mortal Shell 2: 3 hours of free gameplay.
  • Valheim: 2 hours of free gameplay.
  • The Sinking City 2: 1 hour of free gameplay.
  • The Mound: Omen of Cthulhu: 2 hours of free gameplay.
  • John Carpenter’s Toxic Commando: 2 hours of free gameplay.
  • Directive 8020: 1 hour and 30 minutes of free gameplay.

Spotlight: Resonance: A Plague Tale Legacy

Among these offerings, 'Resonance: A Plague Tale Legacy' stands out as a must-play experience for 2026. Serving as an essential prequel to the acclaimed Asobo Studio series, this entry manages to innovate on the established formula while retaining the poetic, high-stakes narrative intensity that made its predecessors so beloved. Whether you are a fan of stealth-adventure games or looking for a compelling story-driven title, the two-hour trial offers a perfect window into its dark and atmospheric world.

Comments (0)

Sign in to join the conversation.Sign in

Loading comments...